Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : RQM+ | Dabl Ltd | Medical Labs Memphis - MLM
Deal Size : Inapplicable
Deal Type : Inapplicable
Renal Pelvic Denervation Pilot Trial
Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Hypertension.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 04, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : RQM+ | Dabl Ltd | Medical Labs Memphis - MLM
Deal Size : Inapplicable
Deal Type : Inapplicable